Although circulating estrone-3-sulfate is a major precursor of biologically active estrogen, permeation across the plasma membrane is unlikely to occur by diffusion because of the high hydrophilicity of the molecule. The object of this study was to clarify the involvement of specific transporter(s) in the supply of estrone-3-sulfate to human breast cancer-derived T-47D cells, which grow in an estrogen-dependent manner. The proliferation of T-47D cells was increased by the addition of estrone-3-sulfate, or estradiol, to the cultivation medium. The initial uptake rate of estrone-3-sulfate kinetically exhibited a single saturable component, with K m and V max values of 7.6 M and 172 pmol/mg of protein/min, respectively. The replacement of extracellular Na ϩ with Li ϩ , K ϩ , or N-methylglucamine ϩ had no effect on the uptake of [ 3 H]estrone-3-sulfate. The uptake was strongly inhibited by sulfate conjugates of steroid hormones, but not by estradiol-17␤-glucuronide. Taurocholate and sulfobromophthalein inhibited the uptake, whereas other tested anionic and cationic compounds did not. The expression of organic anion transporting polypeptides, OATP-D and OATP-E, which are candidate transporters of estrone-3-sulfate, was detected by reverse transcription-polymerase chain reaction analysis, although their actual involvement in the uptake of estrogen remains to be clarified. In conclusion, the uptake of estrone-3-sulfate by T-47D cells was mediated by a carrier-mediated transport mechanism, suggesting that the estrogen precursor is actively imported by estrogen-dependent breast cancer cells.
Breast cancer is one of the major types of cancers, and two-thirds of breast tumors are estrogen-dependent (Henderson and Canellos, 1980) , i.e., their cell growth is regulated by estrogens. The biologically active form of estrogen is estradiol, which is synthesized through two main pathways (Tilson-Mallett et al., 1983; Santner et al., 1986) . One is the aromatase pathway, in which aromatase converts androgens to estrogens and the other is the sulfatase pathway, in which steroid sulfatase converts estrone-3-sulfate to estrone. Since sulfatase activity is 50 to 200 times higher than aromatase activity in pre-and postmenopausal patients with breast cancer, the sulfatase pathway is the major source of biologically active estrogen derived from estrone-3-sulfate Pasqualini et al., 1996 Pasqualini et al., , 1997 . Moreover, the circulating plasma concentration of estrone-3-sulfate is about 5 to 10 times higher than that of unconjugated estrogens, and the half-life of estrone-3-sulfate is longer than that of estradiol (Purdy et al., 1961; Ruder et al., 1972; Pasqualini et al., 1996) . Therefore, estrone-3-sulfate is thought to play an important role in the progression of breast cancer as a reservoir of active estrogen, even though estrone-3-sulfate itself is not very active biologically.
The stimulation of proliferation of breast cancer cells by estrone-3-sulfate involves the following sequence of processes: uptake of estrone-3-sulfate into the cells, desulfation by estrogen sulfatase, conversion of estrone to estradiol by 17␤-hydroxysteroid dehydrogenase type I, binding to nuclear estrogen receptor, and the regulation of gene transcription (MacIndoe, 1988; Kuiper et al., 1997; Puranen et al., 1997; Suzuki et al., 2002) . Although the enzymes and the receptor involved in the response of breast cancer cells to estrone-3-sulfate have been well investigated, the transport mechanism of ligands such as estrone-3-sulfate across the plasma membrane remains to be clarified. Since the log P value of estrone-3-sulfate is reported as 1.4, which is significantly lower than that of estrone (4.4) and estradiol (3.9), it would not be easy to cross the plasma membrane by diffusion, although estrone and estradiol are diffusible (Verheugen et al., 1984; Tan et al., 1999) . Estrone-3-sulfate was detected in intact form in the cytosol fraction of MCF-7 cells after incubation with estrone-3-sulfate (Vignon et al., 1980) and exhibited estrogenic effects Pasqualini et al., 1996; Billich et al., 2000) . Accordingly, a specific transporter may be involved in the supply of estrone-3-sulfate to breast cancer cells that show hormone-dependent growth.
Several members of the organic anion transporter (OAT, SLC22A) and organic anion transporting polypeptide (OATP, SLC21A, SLCO) Meier, 2002, 2003) families are already known to transport estrone-3-sulfate. They are expressed mainly in liver, kidney, brain, intestine, and elsewhere, but their expression in breast cancer cells has not been reported. Their K m values for estrone-3-sulfate are in the range of 0.05 to 59 M. Since plasma levels of estrone-3-sulfate fluctuate in the range of 1 to 10 nM in females (Honjo et al., 1987) , these or other transporters may play a role in the uptake of estrone-3-sulfate into cancer cells as the first step of hormone-dependent proliferation.
Recently, Pizzagalli et al. suggested the expression of a steroid sulfate transporter, OATP-B, in the human mammary gland (Pizzagalli et al., 2003) . However, OATP-B mRNA was not detected in estrogen-dependent MCF-7 and T-47D cells, although OATP-D and OATP-E mRNAs were found in these cells. Since OATP-D and OATP-E exhibited transport activity for estrone-3-sulfate when their genes were transiently expressed in HEK293 cells (Tamai et al., 2001) , they may be involved in the transport of estrone-3-sulfate in cancer cells. However, the transporter-mediated uptake of estrone-3-sulfate in estrogen-dependent cells has not previously been examined, although it has been reported in other tissues such as liver, placenta, and brain (Tan et al., 1999; Kitazawa et al., 2000; St-Pierre et al., 2002) . To fully understand the mechanism of proliferation of breast cancer cells, the mechanism of the supply of estrogen to the cells must be clarified. Thus, the purpose of this study is to characterize the transport mechanism of estrone-3-sulfate in estrogen-dependent cells as the first step to identify the transporter molecule in hormone-dependent breast cancer cells.
Materials and Methods

Materials. [
3 H]Estrone-3-sulfate, ammonium salt (1702.0 GBq/ mmol) was purchased from PerkinElmer Life and Analytical Sciences (Boston, MA). T-47D cells were kindly provided by Prof. Takuma Sasaki, Kanazawa University Cancer Research Institute. Fetal calf serum (FCS) was obtained from Invitrogen (Carlsbad, CA). All other reagents were purchased from Sigma-Aldrich (St. Louis, MO) and Wako Pure Chemicals (Osaka, Japan).
T-47D Cell Proliferation Assay. T-47D cells were routinely grown in RPMI 1640 medium (Sigma-Aldrich) containing phenol red and 10% untreated FCS in a humidified incubator at 37°C and 5% CO 2 . For the proliferation assay, FCS was incubated with 0.5% dextran-coated charcoal (DCC) at 4°C overnight, the medium was decanted, and DCC was filtered off (0.2 m) to remove steroid hormones. This procedure was repeated three times. Then T-47D cells were seeded into 96-well plates at a density of 8000 cells/well in phenol red-free RPMI 1640 medium containing 2.5% DCC-treated FCS. At 1 day after seeding, estradiol or estrone-3-sulfate was added at graded concentrations from stock solutions in water or 0.1% dimethyl sulfoxide (DMSO). The negative control was solvent only. At designated days after seeding, the cells were treated with trypsin, and cell numbers were counted. Transport Experiments. Transport experiments were performed as described previously (Tamai et al., 2001) . Briefly, after cultivation of T-47D cells in 15-cm dishes, the cells were harvested and suspended in the transport medium containing 125 mM NaCl, 4.8 mM KCl, 5.6 mM D-glucose, 1.2 mM CaCl 2 , 1.2 mM KH 2 PO 4 , 1.2 mM MgSO 4 , and 25 mM Hepes, adjusted to pH 7.4. The cell suspension and a solution containing a radiolabeled test compound in the transport medium were separately incubated at 37°C for 20 min and then transport was initiated by mixing them. At appropriate times, 150-l aliquots of the mixture were withdrawn, and the cells were separated from the transport medium by centrifugal filtration through a layer of a mixture of silicone oil (SH550; Dow Corning Toray Silicone Co. Ltd., Tokyo, Japan) and liquid paraffin (Wako Pure Chemicals) with a density of 1.03. Each cell pellet was solubilized in 3 N KOH and neutralized with HCl. Then the associated radioactivity was measured by means of a liquid scintillation counter using Clearsol-1 as a liquid scintillation fluid (Nacalai Tesque, Kyoto, Japan).
Reverse Transcription PCR Method. Expression of OATP and OAT transporters in T-47D cells was examined by the RT-PCR method. Single-stranded cDNA was constructed using an oligo(dT) primer (Invitrogen). The following specific primers were originally designed as follows and used for PCR: OATP-A, 5Ј-AAACAAGCT-GCCCACATAGG-3Ј for forward and 5Ј-AGACAGTCGAACAGAAC-GAC-3Ј for reverse; OATP-B, 5Ј-CCTGCCGCTCTTCTTTATCGG-3Ј and 5Ј-GTTGCACGTCGGTAGACCA-3Ј; OATP-C, 5Ј-CACTTGGA-GGCACCTCACA-3Ј and 5Ј-TTCCCAGATGAACCCGAACA-3Ј; OATP-D, 5Ј-CAGGCCATGCTCTCCGAAA-3Ј and 5Ј-CCTCTAACGT-CACCACCGA-3Ј; OATP-E, 5Ј-CCCTGGGAATCCAGTGGATTG-3Ј and 5Ј-GAGAAGAAACGGTATCGGACGA-3Ј; OATP-F, 5Ј-GGA-AATTCCTCAGGCATAGTGG-3Ј and 5Ј-CTCAAGAACGTCCT-TAGGGTC-3Ј; OATP8, 5Ј-GGGAATCATAACCATTCCTACGG-3Ј and 5Ј-CAGATCGTCCTACGTTTAGGAG-3Ј; OAT1, 5Ј-CTGATG-GCTTCTCACAACAC-3Ј and 5Ј-GACCAAGAAGTAACTCAGCC-3Ј; OAT2, 5Ј-GCTGGTTTTACCATCATCGT-3Ј and 5Ј-GAGGATAAT-GCCGGACTCAG-3Ј; OAT3, 5Ј-AAGTGACCTGTTCCGGATAC-3Ј and 5Ј-GTAGTCCGTTTGTCCATACC-3Ј; and OAT4, 5Ј-GGCGT-TATCTCCATTGCTTC-3Ј and 5Ј-TCTCTGACCCAAGGTTAGAG-3Ј. The reaction was performed for 35 cycles at 94°C for 30 s, 58°C (OATPs) or 56°C (OATs) for 30 s, 72°C for 30 s, and final elongation at 72°C for 10 min in the presence of deoxynucleotides and Taq polymerase (Takara Bio Inc., Shiga, Japan). PCR products were analyzed by means of 1% agarose gel (w/v) electrophoresis, and the gel was stained with ethidium bromide to visualize bands. For positive control, PCR reaction was performed using a pcDNA3 vector, including cDNA of OATP-B, -C, -D, -E, or 8 as previously described (Tamai et al., 2000; Nozawa et al., 2004) , human brain MarathonReady cDNA for OATP-A and -F, or human kidney Marathon-Ready cDNA for OAT1, 2, 3, and 4 (BD Biosciences Clontech, Palo Alto, CA) as templates.
Analytical Methods. Cellular protein content was determined according to the method of Bradford by using a Bio-Rad protein assay kit (Bio-Rad, Hercules, CA) with bovine serum albumin as the standard (Bradford, 1976) . Initial uptake rate of estrone-3-sulfate uptake by T-47D cells was evaluated by the uptake at 1 min after subtraction of the uptake in the presence of excess concentration of unlabeled estrone-3-sulfate (1 mM). To estimate kinetic parameters for saturable transport, the initial uptake rate (v) was fitted to the following equation by means of nonlinear least-squares regression analysis using KaleidaGraph (Synergy Software, Reading, PA).
where v and s are the uptake rate and concentration of substrate, respectively, and K m , V max , and k d represent the half-saturation concentration (Michaelis constant), the maximum transport rate, and the apparent nonsaturable first order rate constant, respectively. All data were expressed as means Ϯ S.E.M., and statistical
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at ASPET Journals on October 15, 2017 jpet.aspetjournals.org analysis was performed by the use of Student's t test with P Ͻ 0.05 as the criterion of significance. Cell-to-medium ratio was obtained by dividing the cellular uptake amount by the concentration of test compound in the uptake medium.
Results
Effect of Estradiol and Estrone-3-Sulfate on the Growth of T-47D Cells.
To elucidate the effect of estrone-3-sulfate on the growth of T-47D cells, the cells were treated with estradiol and estrone-3-sulfate. In line with a previous study using estrogen-dependent MCF-7 cells (Billich et al., 2000) , the proliferation of T-47D cells was stimulated by 1 pM estradiol or 100 nM estrone-3-sulfate compared with the cells treated with solvent alone as control (Fig. 1A) . When evaluated at 6 days after seeding, the estrogen-dependent stimulation was increased in a concentration-dependent manner (Fig. 1B) . The values of median effective concentration (EC 50 ) of estradiol and estrone-3-sulfate were calculated as approximately 22.5 fM and 17.1 nM, respectively, by nonlinear regression analysis.
Uptake of Estrone-3-Sulfate by T-47D Cells. Figure 2 shows the time course of the uptake of [
3 H]estrone-3-sulfate (6.1 nM) by T-47D cells in the presence or absence of unlabeled 1 mM estrone-3-sulfate. The uptake of [
3 H]estrone-3-sulfate increased linearly over 3 min. In the presence of unlabeled 1 mM estrone-3-sulfate, no significant increase in the uptake of [
3 H]estrone-3-sulfate was observed over 30 min (Fig. 2) , suggesting that estrone-3-sulfate was hardly taken up into T-47D cells by simple diffusion. Accordingly, in the following experiments, uptake of estrone-3-sulfate at 1 min by T-47D cells was kinetically analyzed after correction by the uptake in the presence of excess concentration of unlabeled estrone-3-sulfate (1 mM).
To characterize the transport mechanism of estrone-3-sulfate, the effect of replacement of Na ϩ with various cations on estrone-3-sulfate uptake was examined (Fig. 3) . When Na ϩ was replaced with K ϩ , Li ϩ , or N-methylglucamine ϩ , the uptake of [ 3 H]estrone-3-sulfate was not significantly different from that in the presence of Na ϩ , suggesting a Na ϩ -independent transport mechanism.
To obtain the kinetic parameters of the uptake of estrone-3-sulfate by T-47D cells, the concentration dependence of estrone-3-sulfate uptake was examined. The uptake of estrone-3-sulfate after subtraction of the value in the presence of 1 mM estrone-3-sulfate was saturable, as shown in Fig. 4 . In the Eadie-Hofstee plot analysis after correction of nonsaturable uptake, which was estimated from the first order rate constant (4.69 Ϯ 0.38 l/mg of protein/min) obtained by the nonlinear least-squares regression analysis, a single straight line was obtained with the kinetic parameters, K m and V max values (mean Ϯ S.E.) of 7.6 Ϯ 1.2 M and 172 Ϯ 21.0 pmol/mg of protein/min, respectively. These results suggested that a single saturable mechanism is involved for the uptake of estrone-3-sulfate by T-47D cells.
To characterize the substrate specificity of the transport system, the inhibitory effects of hormones, their conjugated metabolites, and various organic compounds on [
3 H]estrone-3-sulfate uptake by T-47D cells were examined (Table 1) . Unlabeled estrone-3-sulfate itself exhibited the strongest inhibitory effect (to 34.7% and 6.6% of the control at 5 and 50 M, respectively). The inhibitory effect of DHEAS was significant (to 44.8% of the control at 50 M), but weaker than that of estrone-3-sulfate. Glucuronide conjugate, estradiol-17␤-glucuronide, had no effect at 50 M. Unconjugated steroid hormones all significantly inhibited the uptake of [ 3 H]estrone-3-sulfate; however, their affinities were lower than that of sulfated conjugates, estrone-3-sulfate and DHEAS. Among other organic compounds examined, sulfobromophthalein and taurocholic acid were inhibitory at 100 M (to 18.9 and 69.3% of the control, respectively). Other organic compounds, salicylate, p-aminohippuric acid, tetraethylammonium, cyclosporin A, and digoxin had no effect, whereas probenecid and benzylpenicillin showed slight inhibitory effects.
To identify the transporters which mediate the uptake of estrone-3-sulfate in T-47D cells, we investigated the expression of OATP and OAT transporters, which could potentially transport estrone-3-sulfate, by RT-PCR analysis. Figure 5 , A and B show the positive control for the specific primers for OATP and OAT transporters, respectively (upper panels), and the signals of expression of OATP-D and OATP-E in T-47D cells (lower panels). Thus, OATP-D and OATP-E are candidates to mediate the uptake of estrone-3-sulfate in estrogen-dependent breast cancer cells.
Discussion
Estrone-3-sulfate is a major circulating estrogen and participates in the progression of estrogen-dependent breast cancer (Pasqualini et al., 1989) . It is subjected to desulfation by steroid sulfatase, followed by conversion to biologically active estrogen in tumor tissues. Since steroid sulfatase was detected in the cytoplasm of breast carcinoma cells (Saeki et al., 1999) , estrone-3-sulfate must be transported into the cells across the plasma membrane prior to desulfation. In view of the hydrophilicity of estrone-3-sulfate, the internalization of estrone-3-sulfate is likely to be mediated by a specific transport mechanism, whereas hydrophobic uncon- jugated steroid hormones seem simply to diffuse into the cells (Verheugen et al., 1984) . We examined, in the present study, whether there is a specific transport system that mediates the uptake of estrone-3-sulfate into T-47D breast cancer cells, which are regarded as model cells that show estrogendependent growth.
First of all, we confirmed the estrogen dependence of the cell growth. Treatment with estrone-3-sulfate, or estradiol, increased T-47D cell proliferation with an EC 50 value of 17.1 nM estrone-3-sulfate, which is close to the physiological plasma concentration of estrone-3-sulfate. Since estrone-3-sulfate itself induces a low direct biological response at the estrogen receptor (Kuiper et al., 1997) , the results suggested the internalization of estrone-3-sulfate across the plasma membrane followed by conversion to active unconjugated estrogen in the cells. Accordingly, this study was particularly focused on the uptake of the sulfate conjugate of estrogen by T-47D cells as the first step in the manifestation of estrogen activity.
The time course of estrone-3-sulfate uptake by T-47D cells suggested that the uptake was mediated by a specific transporter(s), since the uptake in the presence of a high concentration of estrone-3-sulfate (1 mM) was significantly decreased (Fig. 2) . The specific uptake of estrone-3-sulfate was not affected by replacement of Na ϩ with Li ϩ , K ϩ , or Nmethylglucamine ϩ (Fig. 3) . Members of the OATP and OAT families are candidates for Na ϩ -independent estrone-3-sulfate uptake transporters. The K m value for estrone-3-sulfate uptake by T-47D cells was calculated to be 7.6 Ϯ 1.2 M (Fig.  4) , which is consistent with the known range of K m values of OATPs and OATs of 0.05 to 59 M (Kusuhara et al., 1999; Cha et al., 2000; Tamai et al., 2001) . Since the plasma concentrations of estrone-3-sulfate is approximately 1 to 10 nM (Honjo et al., 1987) , breast cancer cells may effectively take it up without saturation.
To further characterize the transport mechanism and to identify the transporter involved, an inhibition study on the uptake of estrone-3-sulfate by T-47D cells was performed. The inhibitory effects of sulfate conjugates of steroid hormones such as estrone-3-sulfate and DHEAS were stronger than those of unconjugated steroid hormones, whereas a glucuronide conjugate was not inhibitory. Thus, a sulfate moiety might confer high affinity for the transporter, whereas a glucuronide moiety might be hardly recognized. Since sulfate conjugates have lower ionization constant (pKa) values compared with unconjugated steroids or glucuronide conjugates, these results suggested that an anionic moiety is essential for substrate recognition by the transporter. Because the plasma concentration of sulfate conjugates of steroid hormones is higher than that of unconjugated hormones or their glucuronide conjugates, the transporter should act effectively in the supply of estrogens to breast tumors. In the case of postmenopausal women, androgens and their sulfated conjugates also play an important role in the progression of breast cancer as a source of active estrogen. Since DHEAS is Uptake of estrone-3-sulfate at various concentrations, ranging from 6.1 nM to 20 M was measured at 37°C for 1 min. The saturable uptake was obtained after subtraction of the uptake in the presence of excess of unlabeled estrone-3-sulfate (1 mM) and used for the evaluation of kinetic constants by nonlinear least-squares analysis. The inset shows an EadieHofstee plot of the saturable uptake of estrone-3-sulfate. Each value represents the mean Ϯ S.E.M. (n ϭ 3-4). When error bars are not shown, they are smaller than the symbols.
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present at high concentration (about 1 M) in most postmenopausal patients, it is a major precursor of estrogen (Worgul et al., 1982) . Since DHEAS strongly inhibited the uptake of estrone-3-sulfate, DHEAS may be preferentially taken up into breast cancer cells as well as estrone-3-sulfate, although its affinity for the transporter which transports estrone-3-sulfate may be lower than that of estrone-3-sulfate.
Some members of OATPs, OAT3, and OAT4 can transport sulfate conjugates of steroid hormones (Kusuhara et al., 1999; Saeki et al., 1999; Meier, 2002, 2003) . Among them, OATP-B and OAT4 recognize estrone-3-sulfate with K m values of 9.04 and 1.01 M, respectively, although they have no affinity for glucuronide conjugates of steroid hormones Tamai et al., 2001) . Since the uptake of [ 3 H]estrone-3-sulfate was not inhibited by glucuronide conjugates in T-47D cells, the functional characteristics of OATP-B or OAT4 are consistent with the uptake mechanism in T-47D cells as to the substrate recognition of steroid conjugates. On the other hand, since OATP-A, OATP-C, OATP8, and OAT3 transport sulfate and glucuronide conjugates, these transporters are not likely to be involved in the transport of estrone-3-sulfate in T-47D cells (Kusuhara et al., 1999; Meier, 2002, 2003) . The typical substrates for OATP, taurocholate, and sulfobromophthalein strongly inhibited the uptake of estrone-3-sulfate by T-47D cells, whereas digoxin and cyclosporin A, which interact with OATP, had no effect Meier, 2002, 2003; Nozawa et al., 2003) . Anionic compounds, salicylate and paminohippuric acid, and cationic compound, tetraethylammonium, which are substrates of OAT and OCT, respectively, had negligible effects. These results suggested the characteristics of the transporter for estrone-3-sulfate in T-47D cells is partly similar to those of OATP or OAT transporters. To obtain insight into the nature of the key transporter, we examined the expression of various human OATPs and OATs by RT-PCR analysis (Fig. 5) . We detected the expression of only OATP-D and OATP-E in T-47D cells, in agreement with a previous report (Pizzagalli et al., 2003) . Since OATP-D and OATP-E exhibited transport activity for estrone-3-sulfate when they were transiently expressed in HEK293 cells (Tamai et al., 2000) , they may take part in the uptake of estrone-3-sulfate across the plasma membrane in T-47D cells. However, their functional characteristics have not been well clarified. On the other hand, the expression of OATP-B and OAT4, which can transport estrone-3-sulfate with the similar characteristics as observed in the present study, were not expressed in T-47D cells. Therefore, the key transporter molecule involved in the uptake of estrone-3-sulfate in T-47D cells could not be identified in the present study. It has also been reported that OST␣-OST␤ can accept estrone-3-sulfate as a substrate (Seward et al., 2003) . Therefore, transporters other than OATPs and OATs might also be involved in the uptake of estrone-3-sulfate in T-47D cells, and further studies remain necessary.
In conclusion, in the present study, it was clearly demonstrated that estrone-3-sulfate is taken up by estrogen-dependent T-47D cells via a specific transport mechanism. This is the first demonstration that the major circulating estrogen, estrone-3-sulfate, is supplied to estrogen-dependent breast cancer cells via a specific transporter. Although further study is required to identify the transporter in T-47D cells, such a transporter molecule would be a novel molecular target for therapeutic intervention in estrogen-dependent breast cancer.
